Barclays PLC Nevro Corp Put Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $8.39 Million - $12.6 Million	103,500 Added 495.22%	124,400 $10.1 Million
Q3 2021 Nov 09, 2021	SELL	$101.99 - $166.36 $5.52 Million - $9 Million	-54,100 Reduced 72.13%	20,900 $2.43 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $2.05 Million - $3.26 Million	58,000 Added 341.18%	75,000 $2.92 Million
Q3 2018 Nov 14, 2018	SELL	$44.22 - $75.47 $353,760 - $603,760	-8,000 Reduced 32.0%	17,000 $969,000
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $1.61 Million - $2.05 Million	22,200 Added 792.86%	25,000 $2 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $226,436 - $255,024	2,800	2,800 $254,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.